tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Allarity Therapeutics Maintains NASDAQ Compliance with Bid Price

Allarity Therapeutics Maintains NASDAQ Compliance with Bid Price

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from Allarity Therapeutics, Inc. (ALLR) is now available.

Allarity Therapeutics, Inc. has announced that they have successfully met NASDAQ’s Minimum Bid Price Requirement, ensuring their continued compliance with the stock market’s standards. This development, which is significant for the company’s financial health and investor confidence, has been officially shared in a press release but is not considered filed for legal purposes unless expressly stated in future documents.

Learn more about ALLR stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1